NYMOX PHARMACEUTICAL CORPORATION Weighted Average Share Price Share Options Granted2019
NYMOX PHARMACEUTICAL CORPORATION (NYMXF) reported Weighted Average Share Price Share Options Granted2019 of $2.34 per share for the 9-month period ending 2020-09-30, per its 6-K filed 2020-11-13.
Discontinued › Income Statement › Earnings Per Share
ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019 · last filed 2020-11-13
- 2020-09-30: Weighted Average Share Price Share Options Granted2019 9 month $2.34.
- 2020-06-30: Weighted Average Share Price Share Options Granted2019 6 month $2.34.
| Period end | Weighted Average Share Price Share Options Granted2019 6 month | Weighted Average Share Price Share Options Granted2019 9 month |
|---|---|---|
| 2020-09-30 | $2.34 6-K · filed 2020-11-13 | |
| 2020-06-30 | $2.34 6-K · filed 2020-08-14 |